From the Journals
Latest News
FDA passes on olorofim despite critical need for antifungals
There are only four antifungal classes currently available, and there are few new candidates in the pipeline.
From the Journals
Methotrexate does not impair sperm quality, small study finds
The findings provide reassurance that men can start methotrexate therapy while actively pursuing parenthood.
Latest News
Warts difficult to eradicate in immunocompromised children
Warts completely resolved with treatment in only 24% of children undergoing active cancer treatment.
Latest News
Prognostic factors of SCCs in organ transplant recipients worse compared with general population
SCCs developed most frequently on the head/neck in organ transplant recipients and on the arms/hands in the general population.
Latest News
Low-dose oral minoxidil for hair loss soars after NYT article
Dermatologists are increasingly familiar with the medication, but a popular media report seems to have resulted in a quick uptake.
Latest News
Report eyes complications from microwave energy devices for hyperhidrosis
The study authors recommend questioning patients about hidradenitis suppurativa (HS) history and examining for HS clinical findings before using...
Latest News
Antibiotic prophylaxis may lower SSIs in skin cancer surgery
There’s a lack of evidence from randomized clinical trials of the role of antibiotic prophylaxis in reducing SSI rates among patients undergoing...
Latest News
How does psoriasis affect fertility and birth outcomes?
“The mechanism to link the higher risk of pregnancy loss in patients with psoriasis is not clear,” the authors wrote.
Latest News
Cell activity in psoriasis may predict disease severity and provide clues to comorbidities
Skin samples from patients with psoriasis showed more fibroblast clusters in the upper layers of the skin in moderate to severe cases.
Latest News
Lower racial disparity in melanoma diagnoses in vets than U.S. men overall, study finds
Melanoma was the fourth-most common cancer diagnosed in male VA patients.
Latest News
Scientists discover variants, therapy for disabling pansclerotic morphea
The JAK inhibitor ruxolitinib dramatically improved wound healing and rashes in patients with the very rare disorder.